Intriguing evidence suggests Alzheimer’s disease may have a link to infectious diseases or a microbial mechanism. Could this be the missing link to lead to a cure for Alzheimer’s disease? To advance research that could shed light, and provide hope to the more than 5.7 Americans and 47 million people worldwide living with the disease, the IDSA Foundation established the Alzheimer’s Research Grant now known as the Microbial Pathogenesis in Alzheimer’s Disease Grant, in 2018 to foster further investigation. These grants support research that suggest evidence of an infectious agent or microbial community is correlated to Alzheimer’s disease and promotes novel research in the field of microbial triggers for Alzheimer’s disease.
Applications are now open for the 2021 grant cycle. Up to 1.7 million in grant funding with individual grants ranging between $30,000 – $250,000 will be awarded. More information about the grant and the application process can be found in the FAQ section and the webinars below.
FREQUENTLY ASKED QUESTIONS
- Both members and non-members of IDSA are encouraged to apply. This includes established investigators, academic and health professionals in all disciplines and health-related professions.
- PhD and MDs are encouraged to apply.
- Interdisciplinary research is encouraged, including collaborations between experts in Alzheimer’s research and infectious diseases.
- Clinical and basic scientists are encouraged to apply.International applicants and non-U.S. citizens are eligible to apply.
- Tuesday, June 15, 2021: Applications Open
- Tuesday, September 21, 2021: Deadline Extended – Applications Close
- September-November 2021: Application Review Period
- December 2021: Applicants and Awardees Notified
- January 2022: Grant Cycle Begins
- June 2022: Interim Reports Due
- February 2022: Grant Cycle Ends
For more information:
Contact IDSA Foundation Program Manager, Evelyn Morales at firstname.lastname@example.org
about the funders
Alzheimer’s Germ Quest (ALZgerm.org) is a public benefit corporation with the mission of accelerating and deepening investigations into possible microbial causes of Alzheimer’s disease.
The Benter Foundation was founded in 2007 to help communities and individuals thrive. Since then, the Foundation has invested to advance a more livable Pittsburgh, emphasizing the city’s urban core. Reaching beyond Pittsburgh, the Foundation supports peace building efforts and innovators who create new knowledge to tackle large scale issues. Path breaking solutions are needed in health challenges like Alzheimer’s disease and opioid abuse. The Benter Foundation believes that the battle against Alzheimer’s will be won through innovative scientific research
In 2020 we awarded more than $1 million in grant funds to researchers linking infectious agents in Alzheimer’s disease. Chosen from among 58 exceptional applications, ten awardees are receiving a $100,000 grant, and one is receiving an $8,000 pilot grant to pursue their research.